Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Sitagliptin
84%
Gastric Inhibitory Polypeptide
61%
Antidiabetic Agent
53%
G Protein Coupled Receptor
46%
Peptide YY
46%
Diabetic Obesity
46%
Cannabidiol
46%
Dipeptidyl Peptidase IV Inhibitor
38%
Glucagon-Like Peptide-1
30%
Non Insulin Dependent Diabetes Mellitus
26%
AM251
23%
Incretin
23%
Monotherapy
15%
Endocannabinoid
15%
Cytotoxicity
15%
Western Blot
15%
Combination Therapy
11%
Sturgeon
9%
Glucagon
9%
Calcium Ion
7%
Receptor
7%
Petromyzon
6%
Glucagon Receptor
6%
Peptidase
6%
Cytokine
6%
Medicine and Dentistry
Sitagliptin
92%
Cell Function
49%
Diabetic Obesity
46%
Cannabidiol
46%
Antidiabetic Activity
46%
Glucose Homeostasis
46%
Enteroendocrine Cell
46%
Dipeptidyl Peptidase-4 Inhibitor
46%
Ob/Ob Mouse
26%
Upregulation
23%
Incretin
23%
Cytotoxicity
23%
Secretion (Process)
23%
Hormone Release
23%
Beta Cell
11%
Monotherapy
7%
Insulin Sensitivity
7%
Glucose Tolerance
7%
Biochemistry, Genetics and Molecular Biology
Cell Function
46%
Glucose Homeostasis
46%
Agonist
46%
Peptide YY
46%
Neuropeptide
46%
Cell Growth
46%
Lamprey
46%
Mouse
23%
Paddlefish
13%
Sturgeon
9%
Glucagon
9%
Streptozotocin
9%
Insulin Blood Level
7%
Insulin Release
7%
Real-Time Polymerase Chain Reaction
7%
Gene Expression
7%
Glucagon-Like Peptide-1
7%
Secretion (Process)
7%
Incretin
7%
Ob/Ob Mouse
7%
Gastric Inhibitory Polypeptide
7%
Hormone Release
7%
Western Blot
7%
Insulin Sensitivity
6%
Cytokine
6%
Glucagon Receptor
6%
Glucose Tolerance Test
6%
Glucose Test
6%